MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- DaVita Clinical Research® (DCR®), a provider of clinical research services focused on kidney care as well as a multitude of specialty therapeutic...
DENVER, May 11, 2011 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease...
DENVER, May 10, 2011 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease...
DENVER, May 03, 2011 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease...
DENVER, May 02, 2011 (BUSINESS WIRE) -- DaVita Inc. (NYSE:DVA) today announced results for the quarter ended March 31, 2011. Net income attributable to DaVita Inc. for the quarter ended March 31,...